Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator
The Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator litigation was centralized before Judge Joy Flowers Conti in the Western District of Pennsylvania in October 2021, following Philips's recall of millions of sleep-apnea and ventilator devices over concerns that internal sound-abatement foam could degrade and release particulates or volatile compounds into the airflow patients inhale. The docket developed two structurally distinct claim populations from the outset: an economic-loss track from device owners seeking replacement or refund value, and a personal-injury track alleging respiratory injury or cancer linked to foam exposure.
That dual structure explains the docket's current numbers. With 624 of 1,033 total filed actions still pending, the economic-loss track has substantially wound down — it moved through negotiated settlement and a device-replacement program years into the litigation — while the personal-injury track remains active and has not yet produced a bellwether trial verdict or general-causation ruling in this proceeding. Resolution risk today is concentrated almost entirely in that personal-injury track, where the central open questions are which injury types and exposure durations the evidence will support as causally linked to foam degradation, and how the court structures a bellwether process to test those theories.
This is a useful example of how a single MDL caption can house two claim populations moving at very different speeds: an economic-loss theory that resolved through negotiated settlement mechanics, and a personal-injury theory still working through the more evidence-intensive path toward bellwether trials or a broader settlement framework. Criterica Intelligence's platform tracks this kind of split-track structure — separating resolved claim populations from genuinely open ones — across every active MDL, giving a calibrated, qualitative read on duration and resolution paths rather than a single docket-wide figure. A companion brief on funding considerations for this docket is available through Criterica Capital.
The JPML centralized claims arising from Philips's 2021 recall of CPAP, BiPAP, and ventilator devices over concerns that internal sound-abatement foam could degrade and release particulates or chemicals into the airflow patients breathe, since claims nationwide raised common factual questions about the recall and its causes.
It consolidates an economic-loss track, which moved through a negotiated settlement and device-replacement program relatively early, and a personal-injury track alleging respiratory injury or cancer, which remains active and has not yet reached a bellwether verdict.
Primarily the personal-injury track: which injury types and exposure durations the evidence will support as causally linked to foam degradation, and how the court structures bellwether trials to test those theories.
No. The platform provides a structural read on how the docket is organized and where each claim track sits in its lifecycle, not a prediction of a specific causation finding or claim outcome.
Statistics shown reflect historical or illustrative model outputs derived from real case data. They are not predictions or guarantees of any individual outcome. Litigation results depend on facts, jurisdiction, judge, and counsel, and vary case by case. Model accuracy is subject to selection effects and changing legal dynamics.